I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Evaluate the Efficacy Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 20-45 Years .
emergency contraception
human papillomavirus
cervical cap
flushed skin
cervical cancer
- 0 views
- 16 Feb, 2024
- 1 location
Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
A total of 480 Chinese women aged 18-26 years old were enrolleexperimental group and the control group were randomly assigned in a ratio of 3:1. 360 Chinese women in the experimental group and 120 in the control group. All subjects enrolled in the upper arm deltoid muscle were injected with …
oral contraceptives
human papillomavirus
gardasil
hpv vaccine
vaccination
- 0 views
- 16 Feb, 2024
- 1 location